Beat In-Albon
Director/Board Member chez EVOLVA HOLDING SA
Fortune : 161 037 $ au 31/03/2024
Profil
Beat In-Albon is currently the Vice Chairman at Evolva Holding SA since 2020, the Chairman at Hans Kalbermatten Thermalbad AG since 2021, the Vice Chairman at Lonza Arena AG since 2020, an Independent Director at PolyPeptide Laboratories Holding (PPL) AB, a Non-Executive Director at Deccan Fine Chemicals (India) Pvt Ltd.
since 2019, and an Independent Non-Executive Director at PolyPeptide Group AG since 2021.
Previously, he served as the Chairman at Escientia Switzerland AG from 2020 to 2021, a Non-Executive Director at Siegfried Holding AG from 2011 to 2012, a Director at Siegfried AG from 2009 to 2012, the SVP, Head-Organic Fine & Performance Chemicals at Lonza Group AG in 2006 and 2007, the Executive Vice President-Industrial Services at SGS SA from 2010 to 2012, and the Head-Strategic Projects at Lonza AG from 2016 to 2018.
Dr. In-Albon holds an MBA from the University of Fribourg in 1987 and a doctorate from the same university in 1983.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
POLYPEPTIDE GROUP AG
0,01% | 31/12/2022 | 4 787 ( 0,01% ) | 161 037 $ | 31/03/2024 |
Postes actifs de Beat In-Albon
Sociétés | Poste | Début |
---|---|---|
EVOLVA HOLDING SA | Director/Board Member | 18/04/2023 |
POLYPEPTIDE GROUP AG | Director/Board Member | 01/01/2021 |
Deccan Fine Chemicals (India) Pvt Ltd.
Deccan Fine Chemicals (India) Pvt Ltd. Chemicals: SpecialtyProcess Industries Deccan Fine Chemicals (India) Pvt Ltd. engages in custom manufacturing of active ingredients and advanced intermediates for agro chemical, fine, and specialty chemical sectors. Its products are used in business areas such as crop protection, and pharmaceutical and animal health. The company was founded in 2008 is headquartered in Hyderabad, India. | Director/Board Member | 01/01/2019 |
PolyPeptide Laboratories Holding (PPL) AB
PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Director/Board Member | - |
Hans Kalbermatten Thermalbad AG | Chairman | 01/01/2021 |
Lonza Arena AG | Director/Board Member | 01/01/2020 |
Anciens postes connus de Beat In-Albon
Sociétés | Poste | Fin |
---|---|---|
Escientia Switzerland AG | Chairman | 01/01/2021 |
Lonza AG
Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | Corporate Officer/Principal | 01/01/2018 |
SIEGFRIED HOLDING AG | Director/Board Member | 01/09/2012 |
░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Beat In-Albon
University of Fribourg | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 5 |
---|---|
LONZA GROUP AG | Health Technology |
SGS SA | Commercial Services |
SIEGFRIED HOLDING AG | Health Technology |
EVOLVA HOLDING SA | Consumer Non-Durables |
POLYPEPTIDE GROUP AG | Health Technology |
Entreprise privées | 7 |
---|---|
Siegfried AG
Siegfried AG Chemicals: AgriculturalProcess Industries Founded in 1873, Siegfried AG is a chemical product manufacturing company. The private company is based in Zofingen, Switzerland and is a part of Siegfried Holding AG. | Process Industries |
PolyPeptide Laboratories Holding (PPL) AB
PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Finance |
Lonza AG
Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | Health Technology |
Hans Kalbermatten Thermalbad AG | |
Deccan Fine Chemicals (India) Pvt Ltd.
Deccan Fine Chemicals (India) Pvt Ltd. Chemicals: SpecialtyProcess Industries Deccan Fine Chemicals (India) Pvt Ltd. engages in custom manufacturing of active ingredients and advanced intermediates for agro chemical, fine, and specialty chemical sectors. Its products are used in business areas such as crop protection, and pharmaceutical and animal health. The company was founded in 2008 is headquartered in Hyderabad, India. | Process Industries |
Escientia Switzerland AG | |
Lonza Arena AG |